Sarah Wordsworth

9.8k total citations · 6 hit papers
150 papers, 6.0k citations indexed

About

Sarah Wordsworth is a scholar working on Economics and Econometrics, Genetics and General Health Professions. According to data from OpenAlex, Sarah Wordsworth has authored 150 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Economics and Econometrics, 32 papers in Genetics and 26 papers in General Health Professions. Recurrent topics in Sarah Wordsworth's work include Health Systems, Economic Evaluations, Quality of Life (43 papers), Genomics and Rare Diseases (17 papers) and Genetic factors in colorectal cancer (12 papers). Sarah Wordsworth is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (43 papers), Genomics and Rare Diseases (17 papers) and Genetic factors in colorectal cancer (12 papers). Sarah Wordsworth collaborates with scholars based in United Kingdom, Netherlands and Canada. Sarah Wordsworth's co-authors include James Buchanan, Chris Rogers, Barnaby C Reeves, Jenny C. Taylor, Elizabeth A Stokes, Usha Chakravarthy, Simon Harding, Andrew Lotery, Susan M. Downes and Katharina Schwarze and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Sarah Wordsworth

143 papers receiving 5.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

2012 626 citations Chris Rogers, Sarah Wordsworth et al. profile →
Liberal or Restrictive Transfusion after Cardiac Surgery

2015 489 citations Chris Rogers, Sarah Wordsworth et al. profile →
The challenge of antimicrobial resistance: What economics can contribute

2019 401 citations Laurence Roope, Richard Smith et al. Science profile →
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature

2018 349 citations Katharina Schwarze, James Buchanan et al. Genetics in Medicine profile →
Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome

2018 261 citations Barnaby C Reeves, Elizabeth A Stokes et al. profile →
Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer

2022 88 citations Eric Lim, Tim Batchelor et al. profile →

Peers

Countries citing papers authored by Sarah Wordsworth

Since Specialization

Citations

This map shows the geographic impact of Sarah Wordsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Wordsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Wordsworth more than expected).

Fields of papers citing papers by Sarah Wordsworth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Wordsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Wordsworth. The network helps show where Sarah Wordsworth may publish in the future.

Co-authorship network of co-authors of Sarah Wordsworth

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Wordsworth. A scholar is included among the top collaborators of Sarah Wordsworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Wordsworth. Sarah Wordsworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada 2024 ·JAMA Network Open ·Deirdre Weymann, John Buckell, (unknown), (unknown), (unknown), Samantha Pollard, Jan M. Friedman, Sylvia Stöckler‐Ipsiroglu, Alison M. Elliott, Sarah Wordsworth, James Buchanan, Dean A. Regier	2
2	Paving the path for implementation of clinical genomic sequencing globally: Are we ready? 2024 ·Health Affairs Scholar ·Deborah A. Marshall, (unknown), James Buchanan, Kurt D. Christensen, Geert Frederix, Ilias Goranitis, Maarten J. IJzerman, Jeroen P. Jansen, Tara A. Lavelle, Dean A. Regier, Hadley Stevens Smith, Wendy J. Ungar, Deirdre Weymann, Sarah Wordsworth, Kathryn A. Phillips	5
3	Cost–effectiveness of Alternative NTRK Testing Strategies in Cancer Patients Followed by Histology-Independent Therapy with Entrectinib: an Analysis of Three European Countries 2023 ·Personalized Medicine ·(unknown), Simone Huygens, Matthijs Versteegh, (unknown), Tamás Zelei, Balàzs Nagy, Rositsa Koleva‐Kolarova, Sarah Wordsworth, Maureen Rutten‐van Mölken, (unknown)	2
4	Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation 2023 ·Personalized Medicine ·Rositsa Koleva‐Kolarova, (unknown), Tamás Zelei, (unknown), Balàzs Nagy, Simone Huygens, Matthijs Versteegh, Maureen Rutten‐van Mölken, Sarah Wordsworth, Apostolos Tsiachristas	1
5	Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies 2023 ·Health Technology Assessment ·Jessica Harris, Koen B. Pouwels, Tom Johnson, Jonathan A C Sterne, (unknown), (unknown), Barnaby C Reeves, Umberto Benedetto, Yoon K. Loke, Daniel Lasserson, Brett Doble, (unknown), Sabi Redwood, Sarah Wordsworth, Andrew Mumford, Chris Rogers, Maria Pufulete	6
6	Lessons Learned from the Application of the HEcoPerMed Guidance to Three Modeling Case Studies 2023 ·Personalized Medicine ·Balàzs Nagy, Tamás Zelei, (unknown), Simone Huygens, Matthijs Versteegh, Maureen Rutten‐van Mölken, Rositsa Koleva‐Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, (unknown)	0
7	Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries 2023 ·Personalized Medicine ·(unknown), Tamás Zelei, (unknown), Simone Huygens, Matthijs Versteegh, Maureen Rutten‐van Mölken, Rositsa Koleva‐Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balàzs Nagy	3
8	Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK 2023 ·Personalized Medicine ·Rositsa Koleva‐Kolarova, (unknown), Simone Huygens, Matthijs Versteegh, Maureen Rutten‐van Mölken, (unknown), Tamás Zelei, Balàzs Nagy, Sarah Wordsworth, Apostolos Tsiachristas	2
9	Cost–effectiveness of Genetic-Based Screening Strategies for Maturity-Onset Diabetes of the Young 2023 ·Personalized Medicine ·(unknown), (unknown), (unknown), Tamás Zelei, Zsolt Gaál, (unknown), Simone Huygens, Matthijs Versteegh, Maureen Rutten‐van Mölken, Rositsa Koleva‐Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balàzs Nagy	3
10	Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review 2022 ·Genetics in Medicine ·Padraig Dixon, Edna Keeney, Jenny C. Taylor, Sarah Wordsworth, Richard M. Martin	24
11	Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT 2022 ·Health Technology Assessment ·Eric Lim, Rosie A Harris, Holly E. McKeon, Tim Batchelor, Joel Dunning, Michael Shackcloth, Vladimir Anikin, Babu Naidu, Elizabeth Belcher, Mahmoud Loubani, Vipin Zamvar, Lucy Dabner, (unknown), Elizabeth A Stokes, Sarah Wordsworth, Sangeetha Paramasivan, Alba Realpe, Daisy Elliott, Jane Blazeby, Chris Rogers	45
12	Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine 2021 ·PharmacoEconomics ·(unknown), Simone Huygens, Matthijs Versteegh, (unknown), Tamás Zelei, Balàzs Nagy, Rositsa Koleva‐Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Maureen Rutten‐van Mölken	31
13	Toward the diagnosis of rare childhood genetic diseases: what do parents value most? 2021 ·European Journal of Human Genetics ·Samantha Pollard, Deirdre Weymann, Jessica L. Dunne, (unknown), John Buckell, James Buchanan, Sarah Wordsworth, Jan M. Friedman, Sylvia Stöckler‐Ipsiroglu, Nick Dragojlovic, Alison M. Elliott, Mark Harrison, Larry D. Lynd, Dean A. Regier	29
14	Effectiveness, cost-effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: protocol of a placebo controlled randomised controlled trial with blinding (GAP study) 2020 ·BMJ Open ·Sarah Baos, Chris Rogers, Reyad Abbadi, Aiman Alzetani, Gianluca Casali, (unknown), (unknown), Lucy Culliford, (unknown), Mark Edwards, N J Goddard, Jennifer Lamb, Holly E. McKeon, (unknown), Elizabeth A Stokes, Sarah Wordsworth, Ben Gibbison, Maria Pufulete	6
15	The challenge of antimicrobial resistance: What economics can contribute breakdown → 2019 ·Science ·Laurence Roope, Richard Smith, Koen B. Pouwels, James Buchanan, Lucy Abel, Peter Eibich, Christopher Butler, Pui San Tan, A. Sarah Walker, Julie V. Robotham, Sarah Wordsworth	401
16	The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom 2019 ·Genetics in Medicine ·Katharina Schwarze, James Buchanan, Jilles M. Fermont, Hélène Dreau, Mark Tilley, John Taylor, Pavlos Antoniou, Samantha J.L. Knight, Carme Camps, Melissa M. Pentony, Erika Kvikstad, Steve Harris, Niko Popitsch, Alistair T. Pagnamenta, Anna Schuh, Jenny C. Taylor, Sarah Wordsworth	140
17	Generic and disease-specific estimates of quality of life in macular degeneration: mapping the MacDQoL onto the EQ-5D-3L 2015 ·Quality of Life Research ·Padraig Dixon, Helen Dakin, Sarah Wordsworth	7
18	Short-term cultures of tumour-derived colorectal cancer cells - A novel in vitro model for the evaluation of angiogenesis in colorectal cancer 2012 ·British journal of surgery ·(unknown), Robert Andrews, J Byrne, (unknown), (unknown), Paul Roderick, Connie J. Rogers, James Thompson, Richard Welbourn, Sarah Wordsworth, (unknown)	1
19	Applied Methods of Cost-effectiveness Analysis in Healthcare 2010 ·RePEc: Research Papers in Economics ·Alastair Gray, Philip Clarke, Jane Wolstenholme, Sarah Wordsworth	280
20	Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions 2005 ·Health Technology Assessment ·Brenda J. Wilson, Nicola Torrance, Jill Mollison, Sarah Wordsworth, J. A. Muir Gray, N E Haites, Anthony M. Grant, Marion Campbell, (unknown), Arabella Clarke, Michelle Watson, A Douglas	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact